argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
697.42
+72.12 (11.53%)
At close: Jan 29, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,406,007
Profits / Employee
$520,976
Market Cap
37.18B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
argenx SE News
- 6 days ago - What's Driving the Market Sentiment Around argenx? - Benzinga
- 16 days ago - FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting - Benzinga
- 16 days ago - FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting - Benzinga
- 16 days ago - argenx Announces Annual General Meeting of Shareholders on May 27, 2025 - GlobeNewsWire
- 16 days ago - Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug - Investor's Business Daily
- 16 days ago - Argenx, Halozyme win FDA nod for Vyvgart Hytrulo prefilled syringe - Seeking Alpha
- 17 days ago - Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
- 17 days ago - US FDA approves syringe version of Argenx's immune disorder drug - Reuters